Ravi Yang Sarin's most recent trade in Oncology Institute Inc (The) was a trade of 29,528 Common stock done . Disclosure was reported to the exchange on March 17, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncology Institute Inc (The) | Ravi Yang Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 29,528 | 75,427 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Ravi Yang Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 22,708 | 45,899 | - | 0 | Common Stock | |
| Oncology Institute Inc (The) | Ravi Yang Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 15,994 | 15,994 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Ravi Yang Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 7,197 | 23,191 | - | 0 | Common stock | |
| Oncology Institute Inc (The) | Ravi Yang Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 4,109,771 | 4,109,771 | - | - | Common Stock | |
| Oncology Institute Inc (The) | Ravi Yang Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 523,497 | 523,497 | - | - | Earn Out Rights | |
| Oncology Institute Inc (The) | Ravi Yang Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 348,998 | 348,998 | - | - | Earn Out Rights |